Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives

被引:20
作者
Rocca, Maria A. [1 ,2 ]
Preziosa, Paolo [1 ]
Filippi, Massimo [1 ,2 ]
机构
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy
[2] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Dept Neurol,Inst Expt Neurol, Milan, Italy
关键词
Disease modifying treatments; magnetic resonance imaging; multiple sclerosis; rehabilitation; treatment monitoring; MAGNETIZATION-TRANSFER RATIO; PLACEBO-CONTROLLED TRIAL; SUBCUTANEOUS INTERFERON BETA-1A; BRAIN VOLUME LOSS; STEM-CELL TRANSPLANTATION; WHITE-MATTER PATHOLOGY; SPINAL-CORD VOLUME; HIGH-YIELD PROCESS; GLATIRAMER ACETATE; DOUBLE-BLIND;
D O I
10.1080/14737175.2019.1555038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Advances in magnetic resonance imaging (MRI) technology and analyses are improving our understanding of the pathophysiology of multiple sclerosis (MS). Due to their ability to grade the presence of irreversible tissue loss, microstructural tissue abnormalities, metabolic changes and functional plasticity, the application of these techniques is also expanding our knowledge on the efficacy and mechanisms of action of different pharmacological and rehabilitative treatments. Areas covered: This review discusses recent findings derived from the application of advanced MRI techniques to evaluate the structural and functional substrates underlying the effects of pharmacologic and rehabilitative treatments in patients with MS. Current applications as outcome in clinical trials and observational studies, their interpretation and possible pitfalls in their use are discussed. Finally, how these techniques could evolve in the future to improve monitoring of disease progression and treatment response is examined. Expert commentary: The number of treatments currently available for MS is increasing. The application of advanced MRI techniques is providing reliable and specific measures to better understand the targets of different treatments, including neuroprotection, tissue repair, and brain plasticity. This is a fundamental progress to move toward personalized medicine and individual treatment selection.
引用
收藏
页码:835 / 866
页数:32
相关论文
共 224 条
[61]   Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients [J].
Ernst, Alexandra ;
Sourty, Marion ;
Roquet, Daniel ;
Noblet, Vincent ;
Gounot, Daniel ;
Blanc, Frederic ;
De Seze, Jerome ;
Manning, Liliann .
BRAIN AND COGNITION, 2016, 105 :34-45
[62]   Induced Brain Plasticity after a Facilitation Programme for Autobiographical Memory in Multiple Sclerosis: A Preliminary Study [J].
Ernst, Alexandra ;
Botzung, Anne ;
Gounot, Daniel ;
Sellal, Francois ;
Blanc, Frederic ;
de Seze, Jerome ;
Manning, Liliann .
MULTIPLE SCLEROSIS INTERNATIONAL, 2012, 2012
[63]   MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS) [J].
Fazekas, F ;
Sorensen, PS ;
Filippi, M ;
Ropele, S ;
Lin, X ;
Koelmel, HW ;
Fernandez, O ;
Pozzilli, C ;
O'Connor, P ;
Enriquez, MM ;
Hommes, OR .
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (04) :433-440
[64]   Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial [J].
Filippi, M ;
Rovaris, M ;
Inglese, M ;
Barkhof, F ;
De Stefano, N ;
Smith, S ;
Comi, G .
LANCET, 2004, 364 (9444) :1489-1496
[65]   European study on intravenous immunoglobulin in multiple sclerosis - Results of magnetization transfer magnetic resonance imaging analysis [J].
Filippi, M ;
Rocca, MA ;
Pagani, E ;
Iannucci, G ;
Sormani, MP ;
Fazekas, F ;
Ropele, S ;
Hommes, OR ;
Comi, G .
ARCHIVES OF NEUROLOGY, 2004, 61 (09) :1409-1412
[66]  
Filippi M, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/s41572-018-0041-4, 10.1038/s41572-018-0046-z]
[67]   Brain mapping in multiple sclerosis: Lessons learned about the human brain [J].
Filippi, Massimo ;
Preziosa, Paolo ;
Rocca, Maria A. .
NEUROIMAGE, 2019, 190 :32-45
[68]   Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study [J].
Filippi, Massimo ;
Preziosa, Paolo ;
Meani, Alessandro ;
Ciccarelli, Olga ;
Mesaros, Sarlota ;
Rovira, Alex ;
Frederiksen, Jette ;
Enzinger, Christian ;
Barkhof, Frederik ;
Gasperini, Claudio ;
Brownlee, Wallace ;
Drulovic, Jelena ;
Montalban, Xavier ;
Cramer, Stig P. ;
Pichler, Alexander ;
Hagens, Marloes ;
Ruggieri, Serena ;
Martinelli, Vittorio ;
Miszkiel, Katherine ;
Tintore, Mar ;
Comi, Giancarlo ;
Dekker, Iris ;
Uitdehaag, Bernard ;
Dujmovic-Basuroski, Irena ;
Rocca, Maria A. .
LANCET NEUROLOGY, 2018, 17 (02) :133-142
[69]   Microstructural MR Imaging Techniques in Multiple Sclerosis [J].
Filippi, Massimo ;
Preziosa, Paolo ;
Rocca, Maria A. .
NEUROIMAGING CLINICS OF NORTH AMERICA, 2017, 27 (02) :313-+
[70]   Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage [J].
Filippi, Massimo ;
Rocca, Maria A. ;
Pagani, Elisabetta ;
De Stefano, Nicola ;
Jeffery, Douglas ;
Kappos, Ludwig ;
Montalban, Xavier ;
Boyko, Alexei N. ;
Comi, Giancarlo .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (08) :852-859